Vascular α1A Adrenergic Receptors as a Potential Therapeutic Target for IPAD in Alzheimer's Disease.
Frost M, Keable A, Baseley D, Sealy A, Andreea Zbarcea D, Gatherer M, Yuen HM, Sharp MM, Weller RO, Attems J, Smith C, Chiarot PR, Carare RO.
Frost M, et al. Among authors: gatherer m.
Pharmaceuticals (Basel). 2020 Sep 22;13(9):261. doi: 10.3390/ph13090261.
Pharmaceuticals (Basel). 2020.
PMID: 32971843
Free PMC article.